The Translational Science Intersessions occur in the last week of each quarter, and are taken by students who have completed one of the eight-week core clerkship rotations in that quarter. Students will generally complete four Translational Science Intersessions during their clinical curriculum. These intersessions are meant to present more advanced understanding of state-of-the-art translational science research with students who have had some clinical training. In general the format includes lecture, seminar-type discussions, journal clubs and student presentations with both basic science and clinical faculty. Students choose one small group topic within the general topic to focus the week.
The general topics for these courses are:
- Cancer Director, Albena Dinkova-Kostova, Ph.D.
- Metabolism Director, Stephen Gould, Ph.D.
- Immunology Director, Michael Chattergoon, M.D., Ph.D.
- Infectious Disease Director, Brendan Cormack, Ph.D.
- Regenerative Medicine Director, Robert Stevens, M.D. & Elias Zambidis, M.D., Ph.D.
- Genomic Medicine, Nara Sobreira M.D., Ph.D. & Joann Bodurtha, M.D.
One afternoon in each of these weeks is devoted to a discussion of ethics, using a lecture, case presentation and small group presentation led by faculty from the Berman Institute of Bioethics.
In a second afternoon session, students participating in the Intersession meet in small groups with their Colleges Advisory Program to discuss critical experience from the core clerkships.
Time Commitment and Course Length
This courses run for three to four days.